Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Toxins, 15, 5, S. 342-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2023
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel
- (wer)
-
MDPI AG
- (wann)
-
2023
- Urheber
-
Jankovic, Joseph
Carruthers, Jean
Naumann, Markus
Ogilvie, Patricia
Boodhoo, Terry
Attar, Mayssa
Gupta, Swati
Singh, Ritu
Soliman, John
Yushmanova, Irina
Brin, Mitchell F.
Shen, Jie
- DOI
-
10.3390/toxins15050342
- URN
-
urn:nbn:de:bvb:384-opus4-1071516
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jankovic, Joseph
- Carruthers, Jean
- Naumann, Markus
- Ogilvie, Patricia
- Boodhoo, Terry
- Attar, Mayssa
- Gupta, Swati
- Singh, Ritu
- Soliman, John
- Yushmanova, Irina
- Brin, Mitchell F.
- Shen, Jie
- Universität Augsburg
- MDPI AG
Entstanden
- 2023
Ähnliche Objekte (12)
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Indications
Indications
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Indications
Indications
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Indications